Loading...
New

Surrogacy Market by Type (Gestational Surrogacy and Traditional Surrogacy) and Technology (IVF with ICSI, IVF without ICSI, and IUI): Global Opportunity Analysis and Industry Forecast, 2016–2025

A06580
Pages: 134
Jul 2020 | 978 Views
 
Author(s) : Kavita Joshi, Apoorva Srivastava , Onkar Sumant
Tables: 96
Charts: 02
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Surrogacy Market

Request Now !

The global surrogacy market generated $112.80 million in 2015, and is projected to reach $201.40 million by 2025, growing at a CAGR of 6.1% from 2016 to 2025.

Surrogacy is a method of assisted reproduction in which the intended parents work with a surrogate who carries the baby until birth. There are two types of assisted reproductive procedures that are used for surrogacy, namely, traditional and gestational. Traditional technology involves utilization of surrogate’s eggs, making her biological mother of the baby. While in gestational, the surrogate does not have any type of biological link with the baby. Rise innumber of people suffering from infertility problems including reduced sperm count, problem in egg or sperm production act as high impact rendering factor for growth of the surrogacy market. Factors such as hormonal changes, stress, alcohol consumption, and steroid lead to the rise in infertility cases, thereby, positively impacting the business growth.

Surrogacy-Market-2020-2027

Get more information on this report : Request Sample Pages

 

Most markets are dropping down, owing to the outbreak, including the surrogacy market. The surrogacy market is negatively impacted by the pandemic as most countries adopted lockdown to combat the pandemic. In addition, most fertility clinics across the globe have stopped undertaking new cases of infertility treatment for next few months, till the condition seems to be under control. For instance, on March 17, 2020, the American Society for Reproductive Medicine (ASRM) is sued certain recommendations that included not initiating new cycles of assisted ovulation, intrauterine inseminations (IUIs), in vitro fertilization (IVF), or “non-urgent” egg freezing.

Technological advancements in assisted reproductive technologies, rise in awareness regarding infertility treatment, and growth in number of fertility clinics are expected to drive the surrogacy market growth during the forecast period. However, high cost related to the procedure along with stringent regulations pertaining to surrogacy in several countries restrict growth of market. Various factors that lead to infertility include problem with sperm or egg production, age, genetic factors, and excessive exposure to some chemicals and toxins. Alcohol consumption, steroid use, surgical removal of one of the testicles due to cancer, and diabetes can also result in low sperm count, thereby leading to infertility problems in men.In women, hormonal disorders, benign growths in uterus, abnormal anatomy of the cervix or uterus, blocked fallopian tubes, stress, chemotherapy, kidney, or sickle cell disease may result in infertility. Furthermore, rise in number of fertility clinics along with growth in awareness about fertility treatments such as sperm/egg donation and in-vitro fertilization escalates the adoption of fertility treatments, thereby propelling the business growth. Moreover, rise inprevalence of polycystic ovarian syndrome in women leads to difficulty in conceiving child, resulting in escalated demand for surrogate mother, thereby leading to market expansion. However, stringent regulations pertaining to commercial method along with high cost involved in the procedure hampers the market growth.

Surrogacy market Segmentation

The global surrogacy market is segmented on the basis of type, technology, end user, and region. By type, it is divided into gestational surrogacy and traditional surrogacy. By technology, it is segmented into IVF with intracytoplasmic sperm injection (ICSI), IVF without ICSI, and intrauterine insemination (IUI). On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment review

On the basis of type, gestational surrogacy dominated the global market in 2015, and is anticipated to continue this trend throughout the forecast period, owing to high adoption of gestational technique by surrogacy professionals along with technological advancements. Moreover, high adoption of gestational technique by surrogacy professionals along with technological advancements is expected to drive the segment growth. Furthermore, emotional and legal complexities associated with traditional surrogacy further propels the adoption of gestational surrogacy.

Surrogacy Market
By Type

Your browser does not support the canvas element.

Gestational Surrogacy holds the dominant position in 2015 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By technology, the IVF (with ICSI) segment accounted for the largest market share in 2015. This segment is expected to exhibit a prominent growth rate, attributed to the fact that it has revolutionized male infertility treatment, as it requires smaller number of sperms that are penetrated into egg with the help of injection technique.

Surrogacy Market
By Technology

Your browser does not support the canvas element.

IVF with (ICSI) segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Asia-Pacific presents lucrative opportunities for key players operating in the surrogacy market. Surrogacy in countries such as India is cheaper compared to developed countries such as the U.S. and Canada; thereby, fueling the market growth of surrogacy in this region. Growth of the surrogacy market is supplemented by surge in adoption of gestational surrogacy, fertility types, and rise in fertility tourism. On the other hand, poor technological outreach and cultural barriers of surrogacy, especially IVF types in the less developed countries of Asia-Pacific restrict the market growth.

Surrogacy Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

North America region would exhibit the highest CAGR of 6.4% during 2016-2025.

Get more information on this report : Request Sample Pages

The key players operating in the global surrogacy market include New Hope Fertility Center, IVI RMA Global, Clinic Scanfert, Bourn Hall Fertility Clinic, NOVA IVI Fertility, Houston Fertility Center, Ovation Fertility, Extraordinary Conceptions, Care Fertility Group, Growing Generations LLC.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the surrogacy market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the surrogacy market from 2015 to 2025 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the surrogacy market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the surrogacy market.

Key Market Segments

By Type

  • Gestational surrogacy
  • Traditional surrogacy 

By Technology

  • IVF with ICSI
  • IUI
  • IVF without ICSI

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Market dynamics

3.2.1.Drivers

3.2.1.1.Increase in number of infertility cases globally
3.2.1.2.Alcohol consumption leading to infertility issues
3.2.1.3.Rise in awareness regarding infertility treatment options
3.2.1.4.Growth in prevalence of causative factors

3.2.2.Restraints

3.2.2.1.Impact of COVID-19 on the surrogacy market
3.2.2.2.Stringent regulations pertaining commercial surrogacy

3.2.3.Opportunity

3.2.3.1.Rise in fertility tourism

3.3.COVID-19 impact on the market

CHAPTER 4:SURROGACY MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast, by type
4.1.2.Market size and forecast, by type

4.2.Gestational Surrogacy

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Traditional Surrogacy

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by region

CHAPTER 5:SURROGACY MARKET, BY TECHNOLOGY

5.1.Overview

5.1.1.Market size and forecast (Value)
5.1.2.Market size and forecast (volume)

5.2.IVF with ICSI

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region

5.3.IVF without ICSI

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region

5.4.Intrauterine Insemination

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region

CHAPTER 6:SURROGACY MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast, by region

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by technology

6.2.3.1.U.S. market size and forecast, by type
6.2.3.2.U.S. market size and forecast, by technology
6.2.3.3.Canada market size and forecast, by type
6.2.3.4.Canada market size and forecast, by technology
6.2.3.5.Mexico market size and forecast, by type
6.2.3.6.Mexico market size and forecast, by technology

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by type
6.3.3.Market size and forecast, by technology

6.3.3.1.UK market size and forecast, by type
6.3.3.2.UK market size and forecast, by technology
6.3.3.3.Rest of Europe market size and forecast, by type
6.3.3.4.Rest of Europe market size and forecast, by technology

6.4.Asia-pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by technology

6.4.3.1.India market size and forecast, by type
6.4.3.2.India market size and forecast, by technology
6.4.3.3.Australia market size and forecast, by type
6.4.3.4.Australia market size and forecast, by technology
6.4.3.5.Rest of Asia-Pacific market size and forecast, by type
6.4.3.6.Rest of Asia-Pacific market size and forecast, by technology

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by technology

6.5.3.1.Brazil market size and forecast, by type
6.5.3.2.Brazil market size and forecast, by technology
6.5.3.3.South Africa market size and forecast, by type
6.5.3.4.South Africa market size and forecast, by technology
6.5.3.5.Rest of LAMEA market size and forecast, by type
6.5.3.6.Rest of LAMEA market size and forecast, by technology

CHAPTER 7:COMPANY PROFILES

7.1.NEW HOPE FERTILITY CLINIC

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments

7.2.IVI RMA GLOBAL

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments

7.3.HOUSTON FERTILITY CENTER

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments

7.4.CLINIC SCANFERT

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments

7.5.BOURN HALL FERTILITY CLINIC

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments

7.6.NOVA IVI FERTILITY

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments

7.7.OVATION FERTILITY

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments

7.8.EXTRAORDINARY CONCEPTIONS

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments

7.9.CARE FERTILITY GROUP

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments

7.10.GROWING GENERATIONS LLC

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments

LIST OF TABLES

TABLE 01.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 02.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 03.SURROGACY MARKET FOR GESTATIONAL SURROGACY, BY REGION, 2016–2025 ($MILLION)
TABLE 04.SURROGACY MARKET FOR GESTATIONAL SURROGACY, BY REGION, 2016–2025 (NO. OF CYCLES)
TABLE 05.SURROGACY MARKET FOR TRADITIONAL SURROGACY, BY REGION, 2016–2025 ($MILLION)
TABLE 06.SURROGACY MARKET FOR TRADITIONAL SURROGACY, BY REGION, 2016–2025 (NO. OF CYCLES)
TABLE 07.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 08.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 09.SURROGACY MARKET FOR IVF WITH ICSI, BY REGION, 2015–2025 ($MILLION)
TABLE 10.SURROGACY MARKET FOR IVF WITH ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 11.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 ($MILLION)
TABLE 12.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 13.SURROGACY MARKET FOR IUI, BY REGION, 2015–2025 ($MILLION)
TABLE 14.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 15.GLOBAL SURROGACY MARKET, BY REGION, 2015–2025 ($MILLION)
TABLE 16.GLOBAL SURROGACY MARKET, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 17.NORTH AMERICA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 18.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 19.NORTH AMERICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 20.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 21.U.S. SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 22.U.S. SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 23.U.S. SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 24.U.S. SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 25.CANADA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 26.CANADA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 27.CANADA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 28.CANADA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 29.MEXICO SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 30.MEXICO SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 31.MEXICO SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 32.MEXICO SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 33.EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 34.EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 35.EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 36.EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 37.UK SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 38.UK SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 39.UK SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 40.UK SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 41.REST OF EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 42.REST OF EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 (NO.OF CYCLES)
TABLE 43.REST OF EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 44.REST OF EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 45.ASIA PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 46.ASIA PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 47.ASIA PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 48.ASIA PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 49.INDIA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 50.INDIA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 51.INDIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 52.INDIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 53.AUSTRALIA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 54.AUSTRALIA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 55.AUSTRALIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 56.AUSTRALIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 57.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 58.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 59.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 60.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 61.LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 62.LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 63.LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 64.LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 65.BRAZIL SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 66.BRAZIL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 67.BRAZIL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 68.BRAZIL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 69.SOUTH AFRICA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 70.SOUTH AFRICA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 71.SOUTH AFRICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 72.SOUTH AFRICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 73.REST OF LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 74.REST OF LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 75.REST OF LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 76.REST OF LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 77.NHFC: COMPANY SNAPSHOT
TABLE 78.NHFC: PRODUCT SEGMENTS
TABLE 79.RMA: COMPANY SNAPSHOT
TABLE 80.RMA: SERVICE SEGMENTS
TABLE 81.HOUSTON FERTILITY CENTER: COMPANY SNAPSHOT
TABLE 82.HOUSTON FERTILITY CENTER: OPERATING SEGMENTS
TABLE 83.CLINIC SCANFERT: COMPANY SNAPSHOT
TABLE 84.CLINIC SCANFERT: OPERATING SEGMENTS
TABLE 85.BOURN HALL FERTILITY CLINIC: COMPANY SNAPSHOT
TABLE 86.BOURN HALL FERTILITY CLINIC: PRODUCT SEGMENTS
TABLE 87.NOVA IVI FERTILITY: COMPANY SNAPSHOT
TABLE 88.NOVA IVI FERTILITY: OPERATING SEGMENTS
TABLE 89.OVATION: COMPANY SNAPSHOT
TABLE 90.OVATION: PRODUCT SEGMENTS
TABLE 91.EXTRAORDINARY CONCEPTIONS: COMPANY SNAPSHOT
TABLE 92.EXTRAORDINARY CONCEPTIONS: PRODUCT SEGMENTS
TABLE 93.CARE FERTILITY GROUP: COMPANY SNAPSHOT
TABLE 94.CARE FERTILITY GROUP: OPERATING SEGMENTS
TABLE 95.GROWING GENERATIONS LLC: COMPANY SNAPSHOT
TABLE 96.GROWING GENERATIONS LLC: SERVICES

LIST OF FIGURES

FIGURE 01.SURROGACY MARKET: MARKET SEGMENTATION
FIGURE 02.MARKET DYNAMICS

 
 

This section provides opinions of top-level CXOs in the surrogacy industry. According to them, surrogacy includes different assisted reproductive technology procedures undertaken by couples who cannot conceive naturally. These services are availed to treat infertility. The surrogacy procedures include IVF with ICSI, IVF without ICSI, and IUI. IVF is one of the most widely known fertility services offered by fertility clinics. This treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also requires IVF intervention. 

According to CXOs, the surrogacy market is anticipated to witness a considerable growth in the future, owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, technological advancements in ART procedures, surge in male infertility, and increased incidences of gamete donations. Moreover, rise in number of people suffering from infertility problems including reduced sperm count or problems in egg/sperm production act as high impact rendering factors for growth of the surrogacy market. Factors such as hormonal changes, stress, alcohol consumption, and steroid use have led to rise in infertility cases, thereby positively impacting the market growth. Furthermore, increase in awareness about IVF and surge in popularity of medical & fertility tourism, coupled with advanced ART facilities & treatment options are anticipated to supplement the market growth. However, inadequate reimbursement policies associated with surrogacy procedures are expected to impede the market growth during the forecast period.

They further stated that growth in interest of single parents as well as same-sex couples in experiencing parenthood through surrogacy procedures offered in countries such as the U.S., the UK, and India are expected to present lucrative opportunities for the market expansion. However, the COVID-19 outbreak has hampered the growth of surrogacy market across the globe.


 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Surrogacy Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts